Short Interest in Healios K.K. (OTCMKTS:HLOSF) Expands By 159.5%

Healios K.K. (OTCMKTS:HLOSF) was the target of a large increase in short interest in February. As of February 15th, there was short interest totalling 34,000 shares, an increase of 159.5% from the January 31st total of 13,100 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 340.0 days.

Healios K.K. Stock Performance

Healios K.K. stock remained flat at $2.42 during midday trading on Friday. The business has a 50 day simple moving average of $1.09 and a 200-day simple moving average of $1.35. Healios K.K. has a 12 month low of $0.93 and a 12 month high of $2.42.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.